KimCS, ZhuX. 2009. Lessons from mouse models of thyroid cancer. Thyroid, 19:1317–1331.
3.
PilliT, PrasadKV, JayaramaS, PaciniF, PrabhakarBS. 2009. Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer. Thyroid, 19:1333–1342.
4.
VriensMR, SuhI, MosesW, KebebewE. 2009. Clinical features and genetic predisposition to nonmedullary thyroid cancer. Thyroid, 19:1343–1349.
5.
NikiforovaM, NikiforovYE. 2009. Molecular diagnostics and predictors in thyroid cancer. Thyroid, 19:1351–1361.
6.
SiposJA. 2009. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid, 19:1363–1372.
7.
SippelRS, ChenH. 2009. Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid, 19:1373–1380.
8.
Van NostrandD. 2009. The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer. Thyroid, 19:1381–1391.
9.
SchlumbergerM, ShermanSI. 2009. Clinical trials for progressive differentiated thyroid cancer: patient selection, study design and recent advances. Thyroid, 19:1393–1400.